The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design

By Chao Z.   Cornette J.L.   Berzofsky J.A.   DeLisi C.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1291-1302

Elsevier

Access to resources Recommend Favorite

Challenges in the Search for an HIV Vaccine

By Lemckert Angelique A.C.   Goudsmit Jaap   Barouch Dan h.  

European Journal of Epidemiology, Vol. 19, Iss. 6, 2004-06 ,pp. : 513-516

Springer Publishing Company

Access to resources Recommend Favorite

HIV vaccine strategies

By Nabel G.J.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1945-1947

Elsevier

Access to resources Recommend Favorite

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

By Iorio A.M.   Francisci D.   Camilloni B.   Stagni G.   De Martino M.   Toneatto D.   Bugarini R.   Neri M.   Podda A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3629-3637

Elsevier

Access to resources Recommend Favorite

MMR vaccine in HIV-infected children - potential hazards?

By Goon P.   Cohen B.   Jin L.   Watkins R.   Tudor-Williams G.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3816-3819

Elsevier

Access to resources Recommend Favorite